Literature DB >> 29440168

FOXO Transcription Factors Both Suppress and Support Breast Cancer Progression.

Boudewijn M T Burgering1,2, Tobias B Dansen3, Marten Hornsveld4,2, Lydia M M Smits4,2, Maaike Meerlo4,2, Miranda van Amersfoort5, Marian J A Groot Koerkamp6, Dik van Leenen2, David E A Kloet2, Frank C P Holstege6, Patrick W B Derksen5.   

Abstract

FOXO transcription factors are regulators of cellular homeostasis and putative tumor suppressors, yet the role of FOXO in cancer progression remains to be determined. The data on FOXO function, particularly for epithelial cancers, are fragmentary and come from studies that focused on isolated aspects of cancer. To clarify the role of FOXO in epithelial cancer progression, we characterized the effects of inducible FOXO activation and loss in a mouse model of metastatic invasive lobular carcinoma. Strikingly, either activation or loss of FOXO function suppressed tumor growth and metastasis. We show that the multitude of cellular processes critically affected by FOXO function include proliferation, survival, redox homeostasis, and PI3K signaling, all of which must be carefully balanced for tumor cells to thrive.Significance: FOXO proteins are not solely tumor suppressors, but also support tumor growth and metastasis by regulating a multitude of cellular processes essential for tumorigenesis. Cancer Res; 78(9); 2356-69. ©2018 AACR. ©2018 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29440168     DOI: 10.1158/0008-5472.CAN-17-2511

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  24 in total

1.  Role of RIN1 on telomerase activity driven by EGF-Ras mediated signaling in breast cancer.

Authors:  W Zhang; M L Veisaga; M A Barbieri
Journal:  Exp Cell Res       Date:  2020-10-16       Impact factor: 3.905

2.  The expression and potential mechanism of EGFR and EZH2 in breast cancer.

Authors:  Xiaoqi Tang; Taosheng Zhou; Jiayue Shen; Ming Luo; Huiming Yuan; Denghua Pan; Fu Li
Journal:  Gland Surg       Date:  2021-08

3.  Association of FOXO1 Rs17592236 Polymorphism and Tumor Size in Papillary Thyroid Carcinoma.

Authors:  Shaghayegh Saljooghi; Zahra Heidari; Mohsen Saravani; Mahnaz Rezaei; Saeedeh Salimi
Journal:  Rep Biochem Mol Biol       Date:  2022-07

4.  Sporadic activation of an oxidative stress-dependent NRF2-p53 signaling network in breast epithelial spheroids and premalignancies.

Authors:  Elizabeth J Pereira; Joseph S Burns; Christina Y Lee; Taylor Marohl; Delia Calderon; Lixin Wang; Kristen A Atkins; Chun-Chao Wang; Kevin A Janes
Journal:  Sci Signal       Date:  2020-04-14       Impact factor: 8.192

5.  ΔN63 suppresses the ability of pregnancy-identified mammary epithelial cells (PIMECs) to drive HER2-positive breast cancer.

Authors:  Christopher E Eyermann; Jinyu Li; Evguenia M Alexandrova
Journal:  Cell Death Dis       Date:  2021-05-22       Impact factor: 8.469

6.  Tamoxifen induces fatty liver disease in breast cancer through the MAPK8/FoxO pathway.

Authors:  Liuyun Gong; Hanmin Tang; Zhenzhen Luo; Xiao Sun; Xinyue Tan; Lina Xie; Yutiantian Lei; Mengjiao Cai; Chenchen He; Jinlu Ma; Suxia Han
Journal:  Clin Transl Med       Date:  2020-04-23

7.  Elucidation of dynamic microRNA regulations in cancer progression using integrative machine learning.

Authors:  Haluk Dogan; Zeynep Hakguder; Roland Madadjim; Stephen Scott; Massimiliano Pierobon; Juan Cui
Journal:  Brief Bioinform       Date:  2021-11-05       Impact factor: 13.994

8.  Association of genetic variants of FBXO32 and FOXO6 in the FOXO pathway with breast cancer risk.

Authors:  Haijiao Wang; Hongliang Liu; Lingling Zhao; Sheng Luo; Tomi Akinyemiju; Shelley Hwang; Ying Yue; Qingyi Wei
Journal:  Mol Carcinog       Date:  2021-07-01       Impact factor: 5.139

9.  ER and PI3K Pathway Activity in Primary ER Positive Breast Cancer Is Associated with Progression-Free Survival of Metastatic Patients under First-Line Tamoxifen.

Authors:  Anieta M Sieuwerts; Márcia A Inda; Marcel Smid; Henk van Ooijen; Anja van de Stolpe; John W M Martens; Wim F J Verhaegh
Journal:  Cancers (Basel)       Date:  2020-03-27       Impact factor: 6.639

Review 10.  The Dominant Role of Forkhead Box Proteins in Cancer.

Authors:  Duc-Hiep Bach; Nguyen Phuoc Long; Thi-Thu-Trang Luu; Nguyen Hoang Anh; Sung Won Kwon; Sang Kook Lee
Journal:  Int J Mol Sci       Date:  2018-10-22       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.